Role of Comorbidities in Optimizing Decision-Making for Allogeneic Hematopoietic Cell Transplantation

Allogeneic conventional hematopoietic cell transplantation (HCT) following high-dose, myeloablative conditioning regimens has been used since the 1970’s as potentially curative treatment for patients with malignant, hematological disorders. The toxicities of conditioning regimens have limited conven...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorror, Mohamed L., Storb, Rainer F.
Formato: Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2010
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997746/
https://www.ncbi.nlm.nih.gov/pubmed/21152378
http://dx.doi.org/10.4084/MJHID.2010.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997746/
https://www.ncbi.nlm.nih.gov/pubmed/21152378
http://dx.doi.org/10.4084/MJHID.2010.015

Ejemplares similares